Bristol-Myers Squibb buy Guggenheim
Start price
08.04.26
/
50%
€49.69
Target price
08.04.27
€61.69
Performance (%)
2.94%
Price
17.04.26
€51.15
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 2.94%. This prediction currently runs until 08.04.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bristol-Myers Squibb | 2.341% |
| iShares Core DAX® | 3.593% |
| iShares Nasdaq 100 | 5.810% |
| iShares Nikkei 225® | 4.075% |
| iShares S&P 500 | 4.142% |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (BMY) had its "buy" rating reaffirmed by Guggenheim. They now have a $72.00 price target on the stock.
Ratings data for BMY provided by MarketBeat